Aera Therapeutics
Aera Therapeutics is a biotechnology company that uses its proprietary protein nanoparticle (PNP) delivery platform to help genetic medicines reach their full potential. Aera's platform, which is based on endogenous human proteins, is being developed to address the limitations of current delivery technologies and to extend the reach of genetic medicines to different tissues and applications, thereby benefiting more patients across a broader range of disease areas. In addition, Aera's licensed technology includes a therapeutic enzyme platform based on the discovery of novel, compact, and programmable gene-editing enzymes.
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Aera Therapeutics use?+
We have not yet detected technologies for Aera Therapeutics.
What industry is Aera Therapeutics in?+
Aera Therapeutics operates in the Biopharma industry.
Where is Aera Therapeutics based?+
Aera Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026